Aurous Healthcare Research And Development (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-12-2024
- Paid Up Capital ₹ 2.00 M
as on 16-12-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13.11%
(FY 2022)
- Profit 93.47%
(FY 2022)
- Ebitda -17.08%
(FY 2022)
- Net Worth 15.76%
(FY 2022)
- Total Assets 11.49%
(FY 2022)
About Aurous Healthcare Research And Development (India)
The Corporate was formerly known as Auroville Healthcare Research And Development Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sriraam Thirukumarasubbiah and Pushpa Thirukumarasubbiah serve as directors at the Company.
- CIN/LLPIN
U85190TN2008PTC067659
- Company No.
067659
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aurous Healthcare Research And Development (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sriraam Thirukumarasubbiah  | Director | 08-May-2008 | Current |
| Pushpa Thirukumarasubbiah | Director | 10-Jul-2013 | Current |
Financial Performance of Aurous Healthcare Research And Development (India).
Aurous Healthcare Research And Development (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.11% increase. The company also saw a substantial improvement in profitability, with a 93.47% increase in profit. The company's net worth Soared by an impressive increase of 15.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurous Healthcare Research And Development (India)?
In 2021, Aurous Healthcare Research And Development (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aurous Healthcare Research And Development (India)?
Unlock and access historical data on people associated with Aurous Healthcare Research And Development (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurous Healthcare Research And Development (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurous Healthcare Research And Development (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
